Skip to main content
. 2021 Jun 3;12:675778. doi: 10.3389/fphys.2021.675778

TABLE 8.

Protein expression.

W (n = 7) W-EX (n = 7) SHR (n = 7) SHR-EX (n = 7)
JNK Phosphorylated 1.00 ± 0.31 1.02 ± 0.31 3.46 ± 1.23* 3.38 ± 1.61#
Total 1.00 ± 0.47 0.91 ± 0.40 1.54 ± 0.59 1.09 ± 0.27
p38 Phosphorylated 1.00 ± 0.37 0.85 ± 0.27 1.10 ± 0.18 1.17 ± 0.49
Total 1.00 ± 0.22 0.76 ± 0.22 3.38 ± 1.79* 3.36 ± 2.08
ERK Phosphorylated 1.14 (0.69–1.21) 1.14 (0.99–1.44) 6.03 (2.08–10.8)* 0.90 (0.26–0.99)§
Total 1.00 ± 0.41 0.66 ± 0.24 1.54 ± 0.44* 1.12 ± 0.55
p65 NF-kB Phosphorylated 1.00 ± 0.69 0.96 ± 0.45 1.03 ± 0.49 0.63 ± 0.60
Total 1.00 ± 0.50 0.61 ± 0.17 0.90 ± 0.62 0.90 ± 0.88
IκB Phosphorylated 1.00 ± 0.67 0.75 ± 0.38 1.53 ± 0.73 1.01 ± 0.85
Total 1.00 ± 0.67 0.67 ± 0.26 3.67 ± 1.50* 2.57 ± 1.56#

Data as mean ± standard deviation or median and percentiles. W, Wistar rats; W-EX, exercised Wistar rats; SHR, spontaneously hypertensive rats; SHR-EX, exercised SHR; JNK, Jun N-terminal kinase; ERK, extracellular-signal-regulated kinase; p65 NF-κB, p65 subunit of nuclear factor kappa B; IκB, Inhibitor of nuclear factor kappa B. ANOVA for a 2 × 2 factorial design and Tukey or Kruskal–Wallis and Dunn; *p < 0.05 vs. W; #p < 0.05 vs. W-EX; §p < 0.05 vs. SHR.